EU regulator backs bivalent COVID shots for primary vaccination




  • In Health
  • 2022-12-06 16:45:38Z
  • By Reuters
 

(Reuters) -The European Medicines Agency said on Tuesday its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults.

The recommendation is based on data which shows that primary vaccination with the adapted bivalent vaccines should give rise to a broad immune response in people who have not yet been exposed to or vaccinated against COVID-19, the agency added.

The EMA said it also studied the immune response in unvaccinated people after natural infection with Omicron BA.4/5 strains of the virus.

The safety profile of the adapted vaccines when used as boosters is comparable to that of the original messenger RNA vaccines.

The U.S. Food and Drug Authority (FDA), which did not immediately respond to a Reuters request for comment, is yet to recommend the bivalent shots for initial vaccination against the virus.

The use of the so-called bilavent shots by Pfizer and BioNTech, as well as rival Moderna, is recommended as a booster in the European Union and in United States.

(Reporting by Sinchita Mitra and Bhanvi Satija in Bengaluru; Editing by Maju Samuel)

COMMENTS

More Related News

EU regulator accepts for review Alzheimer
EU regulator accepts for review Alzheimer's treatment from Eisai-Biogen
  • US
  • 2023-01-26 23:47:56Z

The application to the EMA was based on results from a late-stage study that showed the drug slowed down the rate of cognitive decline in patients with early...

FDA vaccine panel to consider recommending annual COVID shots: What we know
FDA vaccine panel to consider recommending annual COVID shots: What we know

The Vaccines and Related Biological Products Advisory Committee meets Thursday to consider how to update guidelines for COVID-19 booster shots.

COVID vaccines are holding up against highly contagious XBB variant, CDC finds
COVID vaccines are holding up against highly contagious XBB variant, CDC finds

CDC data shows the bivalent COVID vaccines protect against the omicron variant known as XBB and its subvariant XBB.1.5.

Updated COVID vaccines prevented illness from latest variants -CDC
Updated COVID vaccines prevented illness from latest variants -CDC
  • US
  • 2023-01-25 18:03:29Z

The analysis found that the updated vaccine, which targets the BA.4 and BA.5 Omicron variants and the original virus strain, helped prevent illness in people...

Fact check: COVID-19 vaccination decreases chances of hospitalization, contrary to post
Fact check: COVID-19 vaccination decreases chances of hospitalization, contrary to post's implication

COVID-19 vaccine decreases the chance of being hospitalized with COVID-19, contrary to a post that wrongly interprets hospitalization data.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health